by lythamcorp | Nov 29, 2024 | PolyPid, PolyPid News
PETACH TIKVA, Israel, Nov. 29, 2024 — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it has received a written notification (the...
by lythamcorp | Nov 29, 2024 | Technology, Zoomd News, Zoomd Technologies
Conference call will be held on November 29, 2024 at 11 AM ET TORONTO, Nov. 29, 2024 — Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, “Zoomd” or the “Company”), the marketing...
by lythamcorp | Nov 26, 2024 | Industrials, S&W Seed Co, SW Seed News
LONGMONT, Colo., Nov. 26, 2024 — S&W Seed Company (Nasdaq: SANW) today announced it has filed its 10-Q for the three months ended September 30, 2024. S&W previously issued preliminary first quarter fiscal 2025 financial results on November 19, 2024. The...
by lythamcorp | Nov 26, 2024 | Healthcare, Shuttle Pharmaceuticals
GAITHERSBURG, Md., Nov. 26, 2024 — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation...
by lythamcorp | Nov 25, 2024 | Industrials, S&W Seed Co, SW Seed News
LONGMONT, Colo., Nov. 25, 2024 — S&W Seed Company (Nasdaq: SANW) today announced it has finalized the voluntary plan of administration (“VA”) process for its subsidiary, S&W Seed Company Australia Pty Ltd (“S&W Australia”)....